Inhibitor Development in Gene Therapy for Haemophilia
June 15 @ 5:00 pm - 6:00 pm
Gene therapy is transforming the treatment landscape of hemophilia, but major questions remain regarding its use in patients with current or past inhibitors. In this webinar, leading experts will discuss the most challenging clinical and immunological questions, from mechanisms of liver-induced tolerance to the management of inhibitors developing after gene transfer, and will debate whether eligibility criteria should evolve in light of emerging data.